Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02600156 · ClinicalTrials.gov registry record · NA
Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02600156: Completed NA study, sponsored by Mayo Clinic.
NCT02600156 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02600156, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The primary purpose of this study is to evaluate the feasibility and safety of MRI-guided focal laser ablation (Laser-Induced Interstitial Thermal Therapy, LITT) to treat low-risk native prostate cancer.
Interventions
- PROCEDURE Focal laser ablation of the prostate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2015-09-01 |
| Est. Completion | 2025-12-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02600156
The ClinicalTrials.gov registry entry for NCT02600156 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Focal laser ablation of the prostate is the first listed.
NCT02600156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02600156 about?
NCT02600156 is a clinical study titled "Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors". The primary purpose of this study is to evaluate the feasibility and safety of MRI-guided focal laser ablation (Laser-Induced Interstitial Thermal Therapy, LITT) to treat low-risk native prostate cancer.
What is the current status of trial NCT02600156?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2015-09-01. Estimated completion is 2025-12-09.
What interventions are being tested in trial NCT02600156?
The interventions under investigation include: Focal laser ablation of the prostate (PROCEDURE).
Who is sponsoring clinical trial NCT02600156?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.